John Reva’s biography, net worth, fact, career, awards and life story

Intro Cricketer
Is Athlete 
Cricketer 
From Guinea 
Papua New Guinea 
Type Sports 
Gender male
Birth 23 September 1990, Port Moresby, Papua New Guinea
Age: 29 years
Star sign Libra
Sports Teams
Papua New Guinea national cricket team

John Reva (born 23 September 1990) is a Papua New Guinean first-class cricketer. He made his first-class debut in the 2015–17 ICC Intercontinental Cup against the Netherlands on 16 June 2015. He made his List A debut in the 2015–17 ICC World Cricket League Championship on 22 June 2015, also against the Netherlands. He made his Twenty20 International debut for Papua New Guinea against Ireland in the 2015 ICC World Twenty20 Qualifier tournament on 15 July 2015. He made his One Day International (ODI) debut on 6 November 2016 against Hong Kong.

In August 2018, he was named in Papua New Guinea’s squad for Group A of the 2018–19 ICC World Twenty20 East Asia-Pacific Qualifier tournament. In March 2019, he was named in Papua New Guinea’s squad for the Regional Finals of the 2018–19 ICC World Twenty20 East Asia-Pacific Qualifier tournament. The following month, he was named in Papua New Guinea’s squad for the 2019 ICC World Cricket League Division Two tournament in Namibia.

In September 2019, he was named in Papua New Guinea’s squad for the 2019 ICC T20 World Cup Qualifier tournament in the United Arab Emirates.

You May Also Like

Patrick Soon-Shiong’s net worth, biography, fact, career, awards and life story

Patrick Soon-Shiong net worth: Patrick Soon-Shiong is a South African-born surgeon and drug developer who has a net worth of $15.5 billion dollars. Patrick Soon-Shiong is currently the richest person in Los Angeles thanks to an extremely lucrative career as a biotech entrepreneur. In 2010, Patrick purchased Magic Johnson’s 4.5% ownership stake in the Los Angeles Lakers. He is the largest Lakers owner outside of the Buss family. With the transaction, Soon-Shiong also acquired four courtside Lakers seats. Soon-Shiong was born to Chinese immigrants in South Africa on July 29, 1952. His parents fled China during World War II and settled in Port Elizabeth, South Africa. After graduating from high school at the age of 16, Patrick earned his medical degree from the University of the Witwatersrand in Johannesburg at the age of 23. He then earned a Master of Science from the University of British Columbia before moving to Los Angeles for surgical training. Soon-Shiong, who now holds over 50 patents, was a member of the UCLA Medical School faculty from 1983 to 1991. From Humble Surgeon to Multi-Billionaire Soon-Shiong left UCLA in 1991 and founded a biotechnology company called Abraxis BioScience. Under Patrick’s leadership, the company eventually developed a revolutionary drug used in the treatment of breast, lung and pancreatic cancers. The drug, Abraxane, was approved by the FDA in 2005 and the European equivalent in 2008 for the treatment of breast cancer when chemotherapy was not working. By 2009, Abraxane generated $315 million in revenue per year. In 2010 Abraxis BioScience, which was still solely owned by Soon-Shiong, was acquired by American biotech company Celgene for $3 billion in cash and stock. Turns out, this acquisition wasn’t even his biggest success in the business world! In 1997, Patrick founded a company called American Pharmaceutical Partners (APP) which manufactured generic intravenous medicines. By 2008, APP was generating $750 million per year in revenue, of which roughly $300 million was pure profit. In July of 2008, Homberg, Germany-based Fresnius SE agreed to acquire APP for $5.6 billion. At the time of the transaction, Patrick Soon-Shiong owned 80% of APP’s shares. Not one to rest on his laurels, Soon-Shiong founded another company called NantWorks in September 2011. Nantworks’s health division NantHealth aims to provide cloud-based data to the healthcare industry. One of the company’s super computers is now able to analyze and transfer the genetic data from a tumor in under a minute.
Read More